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Introduction
 The term Larva Migrans Visceralis (LMV) was first used 
by Beaver et al. [1] in 1952, when the authors reported the 
clinical picture of three children with chronic marked eo-
sinophilia, hepatomegaly, pulmonary damage, fever, and 
cough, all those listed being produced by larval migration 
in lungs with subsequent migration to other organs. Beaver 
et al. [1] used the term LMV to define larval migration in 
the second phase of development in the organs of the inter-
mediate host (humans) [2].
T. canis and T. cati are found throughout the globe with 
a higher frequency in developing countries with a poor 
sanitation system. The human genetic tendency to be sur-
rounded by pets (dogs and cats) also has a decisive factor in 
the spread of this infection [3].
Toxocara genus belongs to the class Nematoda, order 
Ascaridoidea, family and subfamily Ascarinae and includes 
21 species. The species T. canis, T. cati, and T .leonina are 
most commonly implicated in LMV syndrome [4], in 
humans this syndrome is caused by T. canis and T. cati [3].
Mature worms live an average of four months, after six 
months almost all are eliminated spontaneously from the 
body [4]. The T. canis female produces almost 200,000 eggs 
[5], which are sufficiently resistant and can survive for a 
long time in soil [4]. The eggs are not embryonated in faeces 
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Abstract 
Background: Toxocariasis is a parasitic infection with a major risk to children, especially because of their incompletely developed immune system, high 
risk of infection or frequent re-infection, all correlated with living standards and personal hygiene. Toxocariasis occurs most frequently occult. However, 
evident clinical manifestations may be found, due to the migration of larvae in the second stage of development, the degree of toxocara invasion and the 
immune system of the child.
Material and methods: The study presents the evolution peculiarities in a group of 94 children with toxocara monoinvasion compared to a group of 73 
children with the presence of two or more parasitoses. Clinical particularities, representative laboratory indices, treatment and its influence on clinical 
and paraclinical indices were examined.
Results: The presented article compared the most common clinical signs and paraclinic changes in both studied groups. Was examined the specific 
treatment for each group of patients and its action on the laboratory indices and especially the influence of treatment on the antibody titer to T. canis. 
Conclusions: The most common clinical signs were asthenia, weight loss. An increase in eosinophil level is recorded only in the 13.5% in the cases of 
Toxocara monoinvasion and in 15.1% of the cases with Toxocariasis associated with other parasites. Anti-toxocara specific therapy proved to be much 
superior to other medications with a significant reduction in the percentage of eosinophils and total IgE.
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so they are not infectious. Only temperatures of 15-30 ° C 
plus humidity are necessary conditions for the eggs to be 
embryonated and become infectious within 2-5 weeks after 
elimination [6].
The definitive host for T. canis, is the domestic dog, 
where the adult worm populates the animal’s intestinal small 
intestine [3]. The elimination of faeces in public spaces by 
dogs contributes to the zoonotic spread of parasitosis [5].
Infection in children occurs through the ingestion of 
T. canis embrionated eggs [6] by direct contamination of 
the hands, especially from the contact with puppies aged 
between 2 weeks and 6 months and by indirect contact with 
contaminated objects inside or outside the house.
LMV is a syndrome caused by the ingestion of soil 
infected with T. canis eggs [7-9]. Various studies have 
attempted to make a statistical link between the high risk 
of developing toxocariasis in children and various poor 
childhood habits. Some authors have reported the presence 
of pica sdr. in children with toxocariasis with Larva Migrans 
Visceralis syndrome [11-17] most often in the age group 
of 1 to 6 years, with a slight prevalence of boys over girls 
[10]. Two contradictory studies have shown, on the one 
hand, a relationship between the habit of chewing nails and 
toxocariasis [18], while the other showed the absence of this 
relation [7].
The presence of a dog in the house has also been classified 
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as a risk factor for toxocariasis according to some studies 
[8,10,19,12,13,20,21]. However, some authors have pointed 
out that if hygiene measures are kept, this correlation is not 
maintained [8]. Several studies have provided information 
on the relationship between seropositivity at T. canis in 
puppy owners, who had their pets for at least 3 months 
[7,20]. Iddawela et al. have demonstrated that socio-
economic status is not an increased risk for toxocariasis 
[20]. Other authors have shown the relation between 
this parasitosis and the socio-economic status with such 
indicators as low income and lack of education [5,18,22]. 
They have found a connection between the high prevalence 
of toxocariasis and the low level of urbanization or the 
lack of access to sanitary conditions [8,18,23]. Thus, the 
many studies performed in this field had contradictory 
results, but all of them have a common side – toxocariasis 
presents a very varied seroprevalence: from 9.7% to 43% 
in children in various areas of the world [20-22, 24-27]. 
In most cases of invasion with T. canis, infection occurs 
asymptomatically (approximately 44.4% of cases) [28], the 
systemic manifestations reaching only 15.5% of diagnosed 
cases [29].
Because of the variability of clinical signs, a new 
classification of toxocariasis was proposed in the 1992-1993, 
according to which the disease was divided into 3 clinical 
forms: LMV (Larva Migrans Visceralis), OT (Ocular 
Toxocariasis) and occult form of toxocariasis [30, 31].
The proposed classification was presented as a com-
promise between clinical observations of patients, the 
presence of immunopathogenic mechanisms including 
the degree of immunological response and the location 
of the toxocara larvae. In fact, this classification divides 
toxocarosis into the classical, systemic, occult form, and 
compartmentalized (ocular and neurological) forms. The 
last two forms are likely to be classified separately, being the 
last penetration sites of the Toxocara larvae [32].
LMV has been described as a syndrome with marked 
manifestations of hypereosinophilia, hepatosplenomegaly, 
fever, hypergammaglobulinemia [1], leukocytosis, manife-
stations that occur in children from 1 to 5 years, with an 
average duration of 2 years [33].
Various authors have found a correlation between the 
presence of anemia and toxocariasis [1,14, 25, 35, 36, 37, 
38]. Others, (Glickman et al.) found a correlation between 
a leukocytosis of 10 x 109 and a positive ELISA for T. canis 
[34].
Ocular toxocariasis is a clinical form that affects with the 
same frequency women and men and occurs at an early age. 
In literature OT  is described as having a frequency from 0 to 
10% [21, 28, 39] with an average age at the time of occurrence 
from 3 to 11 years [11, 40]. The disease is unilateral in most 
cases with a minimal or moderate degree of inflammation 
[41, 42]. Clinical manifestations are presented through 
peripheral granuloma of the retina in 50% cases, macula in 
25%, and in 25% cases occurs endophthalmitis. Granuloma 
can also appear in the optic nerve [43]. Magnaval et al. 
[44], and Sabrosa and Souza [15] in 2001. reported that 
eosinophilia is usually absent in occult toxocariasis. 
Throughout the history of the study of toxocariasis, 
have been described various types of systemic damage. It all 
began in 1952 when Beaver et al. [1] have described several 
clinical cases of toxocarosis with skin damage. In the same 
year Beaver described 3 cases of hepatomegaly in children 
with toxocariasis, one child also presented splenomegaly. 
These children endure liver biopsy, with an extensive area 
of liver necrosis and inflammation. The authors also found 
eosinophilic leukocytes as well as giant and epithelial cells 
around the areas of necrosis [1].
Other authors, studying the same pathology, did not find 
a direct correlation between splenomegaly [7] and hepa-
tomegaly [34] in patients with toxocariasis, but demonstrated 
the presence of isolated hepatomegaly in patients with this 
parasitosis [7,45]. Studying the incidence of splenomegaly 
and hepatomegaly in patients with toxocariasis, in various 
studies the authors presented a rate of hepatomegaly between 
11 and 85% [14,17,28] and splenomegaly between 20 and 
45%. Despite of such diverse rates of hepatomegaly, a slightly 
elevated level of the liver occurred in nearly 90% of children 
with toxocariasis according to a study in Brazil [46].
Taylor et al. described abdominal pain as one of the 
most common symptoms, especially in children with high 
antibody titres of T. canis [40]. Iddawela et al. have assumed 
that the major cause of abdominal pain is mesenteric 
lymphadenopathy as a response of the intermediate host to 
the migration of the toxocara larvae [20].
Also, in several studies conducted in children with 
toxocariasis, there were found hypoecogenic lymph nodes 
with a diameter of up to 8 mm [47]. Two children with 
pancreatic lymph node were also described. In literature 
there are reports of liver abscesses in toxocariasis [48-50]. 
Between 1996 and 2002 three cases of pleuritis with positive 
ELISA were described for T. canis [51-53].
Some authors have demonstrated the conection between 
bronchial asthma and toxocariasis [45], others have insisted 
that this was possible in patients with atopic and / or 
allergic antecedents [54]. The literature includes multiple 
descriptions of bronchospasm-associated with toxocariasis 
in children [14, 21, 55, 33]. Alderets et al. describe the 
association of wheezing with positive serology for T. canis 
[18]. Other authors reported that such respiratory signs as 
cough are common in children with positive serology for 
toxocariasis [20, 45, 56, 57].
Material and methods
The study included 167 children aged from 3 to 18 years 
who were divided into two research groups: the first included 
94 children diagnosed with toxocariasis monoinvasion, and 
the second group included 73 children, with toxocariasis 
associated with other parasitoses (ascaridosis, oxyuriasis, 
giardiasis). Patients were examined clinically, showing the 
most common clinical and paraclinical signs, the general 
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blood count, biochemical test (ALT and AST), total IgE, 
antibody titer against T. canis.
Results and discussion
The study involved 167 children with chronic visceral 
toxocariasis, 94 of them with toxocara monoinvasion and 
73 in combination with various other parasitoses. The 
duration of the toxocara invasion ranged from 1 to 9 years, 
the majority of 117 (70.1%) with a duration of 2-7 years.
The age of children with toxocara monoinvasion was 
presented by next values: age category 4-7 years constituted 
22.3%, 8-12 years 38.3% and 13-18 years 39.4%. In these pa-
tients the bronchopulmonary form prevailed in 32 children 
(34.0%) followed by the neurological form in 30 children 
(31.9%), cutaneous form in 16 children (17.0%), digestive 
form in 10 children (10.5%) and other clinical variants in 6 
children (7.3%).
The spreading of the process demonstrated the involve-
ment of a single organ system in the pathological process in 
33 cases (35.1%), two systems in 39 cases (41.5%) and three 
and more systems in 22 cases (23.4%). 
Among the children with toxocariasis associated with 
other parasitoses (ascaridiasis – 25 cases, oxyuria – 18, lam-
bliasis 16, ascaridiasis with oxyuria – 5, ascaridiasis with 
lambliasis – 9), the age category 3-7 years constituted 16,4%, 
8-12 years – 37.0%, and 13-18 years – 46.6%.  The most com-
mon clinical form was neurological with involvement of 25 
children (34.2%), followed by bronchopulmonary clinical 
form in 19 children (26.02% ), digestive form in 14 children 
(19.2%), cutaneous form in 8 children (11%), and other 
manifestations in 7 children (9.6%). Clinical manifestations 
involving only one system were recorded in 26 children 
(35.6%), two systems – 32 children (43.8%), three and more 
affected systems were determined in 15 children (20.5%).
The most frequent clinical manifestations in the group 
with toxocara monoinvasion were headache and long-
standing cough, both in 33% of cases, followed with a de-
crease in percentage value (from 25.5% to 20.3%) by hepa-
tomegaly, vertigo, abdominal pain, diffuse echographic 
changes in liver, skin pruritus, sleep disturbances. The other 
6 clinical signs with a percentage decrease from 20% to 10% 
were: maculo-papular rash, splenomegaly, neuropsychiatric 
disorders (impulsivity, inability to concentrate, poor mem-
ory, chronic apathy, etc.), physical asthenia and weight loss 
(fig. 1).
In the group with toxocariasis associated with other 
parasitoses the most common symptom was headache with 
42.5% followed by abdominal pain in 32.9% of cases, ver-
tigo in 31.5%, sleep disturbance, physical asthenia and long-
standing cough in 27.4%. Thus, within 6 more frequent 
symptoms, 4 were with the involvement of central nervous 
system. These signs of CNS involvement were functional, 
with a gradual decrease to complete disappearance at dif-
ferent time intervals. In toxocariasis associated with other 
parasitoses, asthenia, weight loss, anorexia, pain and weight 
in the right hipocondrium were significantly more common 
compared to toxocara monoinvasion. Long-term cough 
(32.4% versus 24.7%) was reported more frequently in 
toxocara monoinvasion, whereas in toxocariasis associated 
with other parasitoses were found more frequent headache 
Fig. 1.  Percentage distribution of the most common signs in children with chronic visceral toxocariasis in monoinvasion and in 
combination with other parasitoses.
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(42.5% vs. 32.4%), abdominal pain (32.9% vs. 21.6%) and 
vertigo (31.5% vs 24.3%)  (fig. 2).
Clinical manifestations with an incidence of less than 
10% during chronic toxocariasis in children are shown in 
figure 2. In 8.1% of cases of toxocara monoinvasions were 
recorded epileptiform seizures, signs of rhinitis and dys-
pnoea, in 6.8% of cases – bronchopneumonia, in 5.4% of 
cases elevated ALT level. In associated forms more frequent-
ly was observed an increased level of ALT (8.2%).
In the group of patients with associated diseases, non-
specific treatment included antiparasitic therapy (for ascari-
diasis, lambliasis, enterobiosis) with a single dose of benz-
imidazole derivatives, the dose being repeated after 14 days 
only in oxyuria, a three days therapy being given in ascari-
diasis and five days in lambliasis, in all cases being adminis-
tered in only one administration per day. The specific anti-
toxocara treatment included in most cases benzimidazoles 
derivatives, being given twice per day with a dose of 10 mg / 
kg / body with a 10-14 days therapy.
The leukocyte count did not show significant deviations 
from the value of the norm in both groups, but during the 
surveillance it decreased significantly in the group of pa-
tients with specific treatment in the toxocara monoinvasion 
from 6.8 ± 0.47 to 5.5 ± 0.47.
Also, the number of erythrocytes increased compared to 
the values before treatment, being significant in the case of 
toxocara monoinvasion despite of the specific treatment ap-
plied. The percentage values of the lymphocytes had minor 
decrease compared to the baseline in the group with toxo-
cara monoinvasion regardless to the applied therapy, but 
nevertheless remained above the mean values compared to 
the healthy individuals, and in the toxocariasis associated 
with other parasites this index increased from the initial val-
ues. The percentage of eosinophils, which was initially above 
normal values in healthy subjects (6.3 ± 0.61), decreased de-
spite of the treatment applied: in the group with toxocara 
monoinvasion with anti-larval therapy up to 3.7 ± 1.0.
In the groups of children without specific treatment, 
both in the toxocara monoinvasion and toxocariasis asso-
ciated with other parasitoses, the levels of ALT activity in-
creased significantly compared to baseline values in healthy 
individuals. In mono-invasion they increased from 23.8 ± 
2.4 to 62.8 ± 14.2 in the associated forms from 29.8 ± 4.24 
to 45.5 ± 5.23. These liver enzyme behavioral findings dem-
onstrate the direct involvement of toxocara larvae and their 
toxins in the development of hepatic cytolysis syndrome. At 
the same time, in both groups with specific treatment, ALT 
activity remained close to baseline mean values, not differ-
ent from those seen in healthy individuals, demonstrating 
the safety of antilarvaric treatment in children.
Paradoxically, however, in both groups, regardless of 
treatment, antibody levels to T. canis increased, recording 
higher levels than those found up to treatment.
The total IgE level was much higher in the case of toxo-
cara monoinvasion – 302.2 ± 41.0, compared to toxocaria-
sis associated with other parasitoses – 187.6 ± 31.9. Specific 
treatment had a benefic effect on the evolution of total IgE, 
especially in the group of toxocariasis without comorbidi-
ties, recording significantly lower values compared to the 
baseline (145.4 ± 29.2 versus 302.2 ± 41.0). In the case of 
toxocariasis associated with other parasitoses, the total IgE 
level on a background of specific treatment decreased insig-
nificantly, whereas in the group with toxocariasis without 
therapy, on the contrary, increased to 220.7 ± 43.2, com-
pared to 187.6 ± 31.9.
Fig. 2.  Percentage distribution of rare signs in children with chronic visceral toxocariasis in monoinvasion  
and in combination with other parasitoses.
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The separate group analysis based on the specificity of 
the administered therapy revealed different behavior in 
the percentage distribution of clinical efficacy. A total of 56 
(59.6%) children with toxocara monoinvasion were treated 
with anti-larvicidal drugs, while 38 children (40.4%) did not 
receive this treatment. In the course of chronic toxocaria-
sis without comorbidities, a very pronounced clinical effi-
cacy in children with anti-larvaric treatment was recorded 
in 16.1% of cases, whereas in the non-treated group only 
in 5.3% of cases. Clinical efficacy was also pronounced in a 
much higher proportion in the group of patients with anti-
toxocara therapy – 48.2% of the 56 treated versus 23.7% of 
the 38 without treatment.
Of the 73 children with toxocariasis associated with 
other parasitoses, 52 received anti-toxocara therapy, while 
the other 21 followed only the anti-parasitic therapy of co-
morbidities. Very pronounced efficacy was found only in 
7.7% of the 52 patients with treatment and in none of the 
children without anti-toxocara treatment. A clinical effi-
ciency with a decrease in the proportion of 50-75% of the 
previous intensity of clinical signs was found in most pa-
tients with anti-toxocara treatment – 51.9% compared to 
0.0% in those without the treatment. Also, partial clinical 
improvement was more frequent in the group of children 
with toxocariasis with anti-larval treatment with 19.2% of 
cases, compared with 4.8% of cases in children with therapy 
only against other parasitoses. The clinical ineffectiveness of 
anti-toxocara specific therapy was established in 21.2% of 
cases and in 95.2% in children who only followed treatment 
against parasitoses identified as comorbidities.
The level of antibodies to T. canis in children with toxo-
cara monoinvasion who received specific treatment de-
creased to 31 (55.4%) compared to 18 (47.4%) found in 
those without specific therapy. In toxocariasis associated 
with comorbidities, the decrease in the level of the antibod-
ies was 34 (65.4%) in the group with specific treatment and 
only in 2 children in the absence of this therapy. However, 
in both groups after anti-toxocara treatment it was noted 
the increase in antibody levels in approximately 1/3 of pa-
tients: 39.2% of cases from toxocara monoinvasion group 
and 30.8% from the group of toxocariasis associated with 
other parasitoses, although most of these children were with 
clinical improvement.
Conclusions
1. Clinical manifestations during chronic toxocariasis in 
children are very numerous (over 40 clinical signs), varying 
in intensity and incidence, the most common of them being 
headache, dry cough, abdominal pain.
2. In toxocariasis associated with other parasitoses, as-
thenia, weight loss, anorexia, pain and weight in the right 
hippocondrium were significantly more common compared 
to toxocara monoinvasion.
3. Blood hypereosinophilia is recorded in every 6th, 7th 
of the studied children, with a rate of 13.5% in the group 
with toxocara monoinvasion and 15.1% in the group with 
toxocariasis associated with other parasitoses.
4. Specific therapy in chronic visceral toxocariasis in 
children, both in cases of isolated toxocariasis and in com-
bination with other parasitoses, had far superior clinical 
performance compared to other medications, including 
concomitant therapy for the eradication of parasites.
5. Specific treatment significantly reduced the percent-
age of eosinophils in both groups of patients, the IgE level in 
the toxocara monoinvasion group, whereas in the group of 
toxocariasis associated with other parasitoses in the absence 
of anti-larvicidal treatment both IgE total and the percent-
age of eosinophils increased.
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